Innovation Pharmaceuticals Inc. v. Cummings Properties, LLC.

CourtMassachusetts Appeals Court
DecidedAugust 13, 2025
Docket24-P-0638
StatusUnpublished

This text of Innovation Pharmaceuticals Inc. v. Cummings Properties, LLC. (Innovation Pharmaceuticals Inc. v. Cummings Properties, LLC.) is published on Counsel Stack Legal Research, covering Massachusetts Appeals Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Innovation Pharmaceuticals Inc. v. Cummings Properties, LLC., (Mass. Ct. App. 2025).

Opinion

NOTICE: Summary decisions issued by the Appeals Court pursuant to M.A.C. Rule 23.0, as appearing in 97 Mass. App. Ct. 1017 (2020) (formerly known as rule 1:28, as amended by 73 Mass. App. Ct. 1001 [2009]), are primarily directed to the parties and, therefore, may not fully address the facts of the case or the panel's decisional rationale. Moreover, such decisions are not circulated to the entire court and, therefore, represent only the views of the panel that decided the case. A summary decision pursuant to rule 23.0 or rule 1:28 issued after February 25, 2008, may be cited for its persuasive value but, because of the limitations noted above, not as binding precedent. See Chace v. Curran, 71 Mass. App. Ct. 258, 260 n.4 (2008).

COMMONWEALTH OF MASSACHUSETTS

APPEALS COURT

24-P-638

INNOVATION PHARMACEUTICALS INC.

vs.

CUMMINGS PROPERTIES, LLC.

MEMORANDUM AND ORDER PURSUANT TO RULE 23.0

The question before us is whether the plaintiff, Innovation

Pharmaceuticals Inc. (IPI), provided sufficient notice to its

landlord, defendant Cummings Properties, LLC (Cummings), that

IPI was not extending its commercial lease, so as to prevent the

lease from automatically extending for another five years. The

lease required a specific type of written notice to opt out of

the automatic extension provision, and IPI did not comply with

this notice requirement. IPI claims that it nevertheless

provided sufficient notice, because in 2018, during the time

period set by the lease for opting out of the automatic

extension, IPI had multiple e-mail and oral communications with Cummings in which IPI expressed its "intent" to move to a

different location.

The trial judge rejected IPI's argument. In a detailed,

fifty-two-page memorandum, the judge found that although the

parties certainly discussed IPI's interest in leasing a smaller

space, "IPI never gave definitive written notice . . . or even

clear oral notice (albeit not in compliance with [the lease])

that IPI was . . . deciding against renewing the lease." In so

ruling the judge considered and distinguished our recent

decision in Sourcing Unlimited, Inc. v. Cummings Props., LLC,

102 Mass. App. Ct. 653 (2023) (Sourcing Unlimited), which

addressed the identical notice language in a Cummings lease,

reasoning that in Sourcing Unlimited the notice was "unequivocal

and timely" (although by an unauthorized method), whereas in

this case "no such unequivocal notice" was provided.

Accordingly, the trial judge ruled in favor of Cummings and

awarded it $810,251 in liquidated damages.

On appeal IPI presses two principal arguments. First, IPI

insists, based on the testimony of a Cummings employee, Joseph

Martin, that Cummings had actual knowledge that IPI did not

intend to continue with the lease. IPI argues that the judge

failed to address Martin's testimony regarding his alleged

actual knowledge, and that under our case law, actual notice is

sufficient as a matter of law. IPI's second argument is more of

2 a legal argument -- IPI contends that regardless of the notice

provisions in the lease, notice is "adequate" if it "conveys

with reasonable certainty that the notifying party does not

intend to continue," and that IPI provided such notice here.

IPI also challenges the enforcement of the liquidated damages

provision in the lease.

For the reasons discussed below, we are not persuaded. IPI

failed to comply with the notice provision of the lease, and the

facts it relies upon for notice here involve tentative or

preliminary communications, much less definite than those that

justified the exception we recognized in Sourcing Unlimited.

Moreover, the contractual notice provision is clear, and

generally we enforce contractual provisions as written; we

disagree with IPI's effort to in essence rewrite the contractual

notice provision to make it more subjective and less clear. The

liquidated damages provision is also enforceable under our case

law. We accordingly affirm.

Background. "We recite the trial judge's relevant findings

of fact, supplemented with undisputed evidence from the record."

Allison v. Eriksson, 479 Mass. 626, 627 (2018). IPI is a

publicly traded biopharmaceutical company that regularly engages

3 in complex commercial transactions. 1 Cummings is a commercial

real estate management company that leases real estate for

purposes including office and laboratory space.

1. Provisions of the lease. In July of 2008, IPI and

Cummings executed a commercial lease for laboratory space in

Beverly (2008 lease). The term of the 2008 lease was five

years, from October 1, 2008, to September 30, 2013. Dr. Krishna

Menon (Dr. Menon), who was then the Chief Science Officer of

IPI, signed the lease on behalf of IPI. 2

The 2008 lease contained several provisions relevant to

this appeal. As to extensions of the lease, Paragraph M of an

attached rider provided IPI with a one-time option to extend the

lease for five years. To exercise this option, IPI was required

to serve Cummings with written notice not earlier than twelve

months, nor later than six months, prior to the expiration of

the initial lease term.

The original lease extension period, from October 2012 to

March 2013, expired without IPI exercising its option to extend.

However, in August of 2013, IPI and Cummings executed a document

1 Prior to May of 2017, the company's name was Cellceutix. For convenience, we refer to the plaintiff company as IPI throughout.

2 KARD, Inc. (KARD), a company owned by Dr. Menon and members of his family, was also a co-lessee. KARD is not a party to this appeal.

4 titled "Lease Extension #1" (2013 extension), which extended the

lease by five years. The 2013 extension was also signed by Dr.

Menon, this time as President of IPI.

The 2013 extension included the following provision

(automatic extension provision):

"The lease, including all terms, shall be automatically extended for additional successive periods of five year(s) each unless LESSOR or LESSEE serves written notice, either party to the other, of either party's option not to so extend the lease. The time for serving such written notice shall be not more than 12 months or less than six months prior to the expiration of the then-current lease period. Time is of the essence."

Accordingly, the 2013 extension imposed on IPI the obligation to

give written notice that IPI was exercising its option not to

extend, between October 1, 2017, through March 30, 2018; if IPI

did not do so, the lease would automatically extend.

As to the manner of notice, Section 21 of the 2008 lease,

titled "NOTICE," included the following:

"Any notice from LESSEE to LESSOR under this lease shall be given in writing and shall be deemed duly served only when served by constable, or delivered to LESSOR by certified or registered mail, return receipt requested, postage prepaid, or by recognized courier service with a receipt therefor, addressed to LESSOR at [Cummings's address]. No oral, facsimile or electronic notice shall have any force or effect. Time is of the essence in the service of any notice."

Thus, for IPI to exercise its option not to extend, it needed to

provide written notice in accordance with the provisions of

Section 21, by March 30, 2018.

5 2. Facts regarding notice.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Carey v. Planning Board of Revere
141 N.E.2d 895 (Massachusetts Supreme Judicial Court, 1957)
Freelander v. G. & K. REALTY CORP.
258 N.E.2d 786 (Massachusetts Supreme Judicial Court, 1970)
Trinity Realty I, LLC v. Chazumba, LLC
931 N.E.2d 510 (Massachusetts Appeals Court, 2010)
Allison v. Eriksson
98 N.E.3d 143 (Massachusetts Supreme Judicial Court, 2018)
Commissioner of Corporations & Taxation v. City of Springfield
71 N.E.2d 593 (Massachusetts Supreme Judicial Court, 1947)
Buster v. George W. Moore, Inc.
438 Mass. 635 (Massachusetts Supreme Judicial Court, 2003)
TAL Financial Corp. v. CSC Consulting, Inc.
844 N.E.2d 1085 (Massachusetts Supreme Judicial Court, 2006)
Cummings Properties, LLC v. National Communications Corp.
869 N.E.2d 617 (Massachusetts Supreme Judicial Court, 2007)
NPS, LLC v. Minihane
886 N.E.2d 670 (Massachusetts Supreme Judicial Court, 2008)
Gerson Realty Inc. v. Casaly
316 N.E.2d 767 (Massachusetts Appeals Court, 1974)
Cadillac Automobile Co. v. Stout
477 N.E.2d 1048 (Massachusetts Appeals Court, 1985)
Computune, Inc. v. Tocio
691 N.E.2d 994 (Massachusetts Appeals Court, 1998)
President & Fellows of Harvard College v. PECO Energy Co.
787 N.E.2d 595 (Massachusetts Appeals Court, 2003)
Chace v. Curran
881 N.E.2d 792 (Massachusetts Appeals Court, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Innovation Pharmaceuticals Inc. v. Cummings Properties, LLC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/innovation-pharmaceuticals-inc-v-cummings-properties-llc-massappct-2025.